These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38926773)
1. Diagnostic performance of plasma pTau Arranz J; Zhu N; Rubio-Guerra S; Rodríguez-Baz Í; Ferrer R; Carmona-Iragui M; Barroeta I; Illán-Gala I; Santos-Santos M; Fortea J; Lleó A; Tondo M; Alcolea D Alzheimers Res Ther; 2024 Jun; 16(1):139. PubMed ID: 38926773 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Arranz J; Zhu N; Rubio-Guerra S; Rodríguez-Baz Í; Ferrer R; Carmona-Iragui M; Barroeta I; Illán-Gala I; Santos-Santos M; Fortea J; Lleó A; Tondo M; Alcolea D Res Sq; 2023 Dec; ():. PubMed ID: 38168408 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer's Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms. Dakterzada F; Cipriani R; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Matute C; Capetillo-Zarate E; Piñol-Ripoll G Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731812 [TBL] [Abstract][Full Text] [Related]
4. Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment. Garrett SL; McDaniel D; Obideen M; Trammell AR; Shaw LM; Goldstein FC; Hajjar I JAMA Netw Open; 2019 Dec; 2(12):e1917363. PubMed ID: 31834392 [TBL] [Abstract][Full Text] [Related]
9. Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse. Alcolea D; Pegueroles J; Muñoz L; Camacho V; López-Mora D; Fernández-León A; Le Bastard N; Huyck E; Nadal A; Olmedo V; Sampedro F; Montal V; Vilaplana E; Clarimón J; Blesa R; Fortea J; Lleó A Ann Clin Transl Neurol; 2019 Sep; 6(9):1815-1824. PubMed ID: 31464088 [TBL] [Abstract][Full Text] [Related]
10. Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease. Abdelnour C; Young CB; Shahid-Besanti M; Smith A; Wilson EN; Ramos Benitez J; Vossler H; Plastini MJ; Winer JR; Kerchner GA; Cholerton B; Andreasson KI; Henderson VW; Yutsis M; Montine TJ; Tian L; Mormino EC; Poston KL Ann Neurol; 2024 Sep; 96(3):526-538. PubMed ID: 38888142 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting. Jung NY; Kim ES; Kim HS; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Lee EC; Seong JK; Huh GY; Kim DS; Kim EJ J Alzheimers Dis; 2020; 74(2):473-490. PubMed ID: 32039853 [TBL] [Abstract][Full Text] [Related]
12. CSF Aβ Rizzi L; Maria Portal M; Batista CEA; Missiaggia L; Roriz-Cruz M Brain Res; 2018 Jan; 1678():27-31. PubMed ID: 29017912 [TBL] [Abstract][Full Text] [Related]
13. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653 [TBL] [Abstract][Full Text] [Related]
14. Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine. Chiasserini D; Biscetti L; Farotti L; Eusebi P; Salvadori N; Lisetti V; Baschieri F; Chipi E; Frattini G; Stoops E; Vanderstichele H; Calabresi P; Parnetti L J Alzheimers Dis; 2016 Jul; 54(1):55-67. PubMed ID: 27447425 [TBL] [Abstract][Full Text] [Related]
15. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform. Ho S; Darrow J; De Simone F; Calabro A; Gannon S; Esquivel R; Thakker P; Khingelova K; Rao A; Zhang Y; Moghekar A J Appl Lab Med; 2024 Jul; 9(4):789-802. PubMed ID: 38712812 [TBL] [Abstract][Full Text] [Related]
17. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723 [TBL] [Abstract][Full Text] [Related]
18. Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment. Parnetti L; Chiasserini D; Eusebi P; Giannandrea D; Bellomo G; De Carlo C; Padiglioni C; Mastrocola S; Lisetti V; Calabresi P J Alzheimers Dis; 2012; 29(1):229-38. PubMed ID: 22232006 [TBL] [Abstract][Full Text] [Related]
19. The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone. Delaby C; Estellés T; Zhu N; Arranz J; Barroeta I; Carmona-Iragui M; Illán-Gala I; Santos-Santos MÁ; Altuna M; Sala I; Sánchez-Saudinós MB; Videla L; Valldeneu S; Subirana A; Tondo M; Blanco-Vaca F; Lehmann S; Belbin O; Blesa R; Fortea J; Lleó A; Alcolea D Alzheimers Res Ther; 2022 Feb; 14(1):20. PubMed ID: 35105351 [TBL] [Abstract][Full Text] [Related]
20. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL; Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]